Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Payables (2016 - 2025)

InspireMD filings provide 16 years of Payables readings, the most recent being $9.5 million for Q4 2025.

  • On a quarterly basis, Payables rose 47.21% to $9.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.5 million, a 47.21% increase, with the full-year FY2025 number at $9.5 million, up 47.21% from a year prior.
  • Payables hit $9.5 million in Q4 2025 for InspireMD, up from $1.8 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $9.5 million in Q4 2025 to a low of $401000.0 in Q1 2021.
  • Median Payables over the past 5 years was $3.5 million (2021), compared with a mean of $3.4 million.
  • Biggest five-year swings in Payables: skyrocketed 1363.56% in 2021 and later plummeted 80.92% in 2022.
  • InspireMD's Payables stood at $3.5 million in 2021, then plummeted by 80.92% to $659000.0 in 2022, then soared by 671.02% to $5.1 million in 2023, then rose by 26.43% to $6.4 million in 2024, then surged by 47.21% to $9.5 million in 2025.
  • The last three reported values for Payables were $9.5 million (Q4 2025), $1.8 million (Q3 2025), and $7.6 million (Q2 2025) per Business Quant data.